We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay.
- Authors
Salvagno, Gian Luca; Henry, Brandon M.; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gian Luca; Lippi, Giuseppe
- Abstract
Keywords: antibodies; COVID-19; immune response; SARS-CoV-2; vaccination EN antibodies COVID-19 immune response SARS-CoV-2 vaccination e377 e379 3 09/08/21 20210901 NES 210901 To the Editor, We read with interest the article of Padoan and colleagues [[1]], who thoughtfully assessed the analytical and clinical characteristics of the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain (RBD) IgG chemiluminescent immunoassay recently commercialized by Snibe diagnostics (New Industries Biomedical Engineering Co., Ltd [Snibe], Shenzhen, China). Antibodies, COVID-19, immune response, SARS-CoV-2, vaccination.
- Subjects
MEDICAL personnel; COVID-19 vaccines; SARS-CoV-2; IMMUNOGLOBULIN G; COVID-19
- Publication
Clinical Chemistry & Laboratory Medicine, 2021, Vol 59, Issue 10, pe377
- ISSN
1434-6621
- Publication type
Letter
- DOI
10.1515/cclm-2021-0687